AURX
Nuo Therapeutics, Inc.Company Information
- Company Name
- Nuo Therapeutics, Inc.
- CIK
- CIK0001091596
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- AURX: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- AURX
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-07-30
- Last sale
- 2025-11-28
- Shares purchased (TTM)
- 133,333
- Shares sold (TTM)
- 200,000
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 4,700
- Shares outstanding
- 48,285,303
- Ownership
- 0.01%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 57.14%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | ||||||
| Restricted Cash Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Accounts Receivable Net Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | ||||||
| Property Plant And Equipment Net | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Revenue Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Deferred Revenue Noncurrent | 1 | 1 | 1 | 1 | 1 | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 4 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 34 | 34 | 34 | 34 | 33 | 33 | 33 | 33 | 32 | 31 | 31 | 30 | ||||||
| Retained Earnings Accumulated Deficit | -36 | -35 | -35 | -34 | -34 | -33 | -32 | -32 | -31 | -31 | -30 | -29 | ||||||
| Stockholders Equity | -2 | -1 | -1 | -0 | -1 | -0 | 1 | 1 | 1 | 0 | 1 | 1 | ||||||
| Liabilities And Stockholders Equity | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 48 | 48 | 48 | 48 | 47 | 47 | 47 | 47 | 45 | 44 | 44 | 42 | ||||||
| Shares Outstanding | 48 | 48 | 48 | 48 | 47 | 47 | 47 | 47 | 45 | 44 | 44 | 42 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNuo Therapeutics, Inc. (AURX) — SEC Financial Statements & Analysis
Nuo Therapeutics, Inc. (AURX) is a surgical & medical instruments & apparatus company, incorporated in DE. Nuo Therapeutics, Inc. trades on OTC as: AURX. Nuo Therapeutics, Inc. (AURX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Nuo Therapeutics, Inc. carries a market cap of $48.89M, a P/E ratio of -24.29x, a P/B ratio of -31.84x, a P/S ratio of 9.40x, an enterprise value of $48.44M, and an EV/EBITDA multiple of -29.59x. On profitability, it posts a gross margin of 64.11%, an operating margin of -33.32%, a net margin of -38.70%, a Return on Equity (ROE) of 170.56%, a Return on Assets (ROA) of -100.98%, and a Return on Invested Capital (ROIC) of -1293.81%. Per share, it reports EPS of $-0.04, free cash flow per share of $-0.05, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 166.61% year-over-year, net income growth of -18.55% year-over-year, and EPS growth of -21.21% year-over-year. On the balance sheet, it maintains a current ratio of 1.28x, a quick ratio of 1.04x, working capital of $439.43K, a debt-to-equity ratio of -2.71x, a debt ratio of 1.58, an interest coverage ratio of -5.96x, free cash flow of $-2.45M (TTM), and net debt of $-449.32K. Figures sourced from SEC EDGAR.
- Market Cap
- $48.89M
- P/E TTM
- -24.29x
- EPS TTM
- $-0.04
- P/B TTM
- -31.84x
- ROE TTM
- 170.56%
- ROA TTM
- -100.98%
- Debt To Equity
- -2.71x
- Free Cash Flow TTM
- $-2.45M
- Net Revenue TTM Growth 1Y
- 166.61%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Nuo Therapeutics, Inc. in?
Nuo Therapeutics, Inc. (AURX) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does AURX trade on?
Nuo Therapeutics, Inc. (AURX) trades on the OTC.
Where is Nuo Therapeutics, Inc. incorporated?
Nuo Therapeutics, Inc. is incorporated in DE.
When was Nuo Therapeutics, Inc. (AURX)'s most recent SEC filing?
Nuo Therapeutics, Inc. (AURX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is AURX's market cap?
Nuo Therapeutics, Inc. (AURX) has a market capitalization of $48.89M as of 2026-06-30.
What is AURX's EPS (earnings per share)?
Nuo Therapeutics, Inc. (AURX)'s trailing twelve month EPS is $-0.04 as of 2026-06-30.
What is AURX's ROE (return on equity)?
Nuo Therapeutics, Inc. (AURX)'s trailing twelve month Return on Equity (ROE) is 170.56% as of 2026-06-30.
What is AURX's ROA (return on assets)?
Nuo Therapeutics, Inc. (AURX)'s trailing twelve month Return on Assets (ROA) is -100.98% as of 2026-06-30.
What is AURX's ROIC (return on invested capital)?
Nuo Therapeutics, Inc. (AURX)'s trailing twelve month Return on Invested Capital (ROIC) is -1293.81% as of 2024-12-31.
What is AURX's EV/EBITDA?
Nuo Therapeutics, Inc. (AURX)'s trailing twelve month EV/EBITDA is -29.59x as of 2026-06-30.